Daily as of 3 Nov 16:00 ET
- Price
- below both $20.31 vs 50 $22.11 / 200 $22.47
- Projection
- No cross projected
- Test
- Cross test window open, no test bar yet
- Last cross
- 💀Death cross 30 Oct 2026 · projected 28 bars out
IMNM | ImmunomeNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$20.31
+$0.72 (+3.68%)
Immunome (IMNM) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $18.21 vs 50 $21.90 / 200 $13.57
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $20.37 vs 50 $18.86 / 200 $22.66
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 9 Oct 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 30 Oct 2026 | 💀Death steep | daily | 28 bars out | Active Cross Test |
| 9 Oct 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| 22 Jul 2026 | 🟨Golden | 4-hour | 25 bars out | 1 bar cross test |
| 29 May 2026 | 💀Death | 4-hour | 21 bars out | 2 bar cross test |
| 23 Apr 2026 | 🟨Golden | 4-hour | 24 bars out | Not tested |
About IMNM
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$24.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandmid